ARAF
v-raf murine sarcoma 3611 viral oncogene homolog
ARAF; v-raf murine sarcoma 3611 viral oncogene homolog; ARAF1, v raf murine sarcoma 3611 viral oncogene homolog 1; serine/threonine-protein kinase A-Raf; Oncogene ARAF1; proto-oncogene Pks; proto-oncogene A-Raf-1; Ras-binding protein DA-Raf; v-raf murine;
BCAS2
breast carcinoma amplified sequence 2
BCAS2; breast carcinoma amplified sequence 2; pre-mRNA-splicing factor SPF27; DAM1; Snt309; SPF27; DNA amplified in mammary carcinoma 1 protein; Spliceosome associated protein SPF 27; Breast carcinoma-amplified sequence 2; MGC7712; Pre mRNA splicing factor SPF27; SPF27_HUMAN; Spliceosome associated protein amplified in breast cancer; Spliceosome-associated protein SPF 27; OTTHUMP00000013668; spliceosome associated protein, amplified in breast cancer;
BRAF
v-raf murine sarcoma viral oncogene homolog B1
BRAF; v-raf murine sarcoma viral oncogene homolog B1; serine/threonine-protein kinase B-raf; BRAF1; p94; 94 kDa B-raf protein; proto-oncogene B-Raf; murine sarcoma viral (v-raf) oncogene homolog B1; B-Raf proto-oncogene serine/threonine-protein kinase (p9;
CEACAM1
CEACAM1 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
CEACAM1; carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); BGP; carcinoembryonic antigen-related cell adhesion molecule 1; BGP1; CD66a; antigen CD66; CD66a antigen; BGPI; Arcitumomab; CEA-Scan; 154361-48-5;
CEACAM3
carcinoembryonic antigen-related cell adhesion molecule 3
CEACAM3; carcinoembryonic antigen-related cell adhesion molecule 3; CGM1; CD66d; CD66d antigen; carcinoembryonic antigen CGM1; nonspecific cross-reacting antigen; carcinoembryonic antigen gene family member 1; CEA; W264; W282; CD66D; MGC119875;
CEACAM5
carcinoembryonic antigen-related cell adhesion molecule 5
CEACAM5; carcinoembryonic antigen-related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100; DKFZp781M2392;
CEACAM6
CEACAM6 carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
CEACAM6; carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen); NCA; CEAL; CD66c; carcinoembryonic antigen-related cell; CD66c antigen; Non-specific crossreacting antigen; carcinoembryonic antigen-related cell; adhesion molecule 6; Sulesomab; LeukoScan; 167747-19-5;
CEACAM8
carcinoembryonic antigen-related cell adhesion molecule 8
CEACAM8; carcinoembryonic antigen-related cell adhesion molecule 8; CGM6; CD66b; CD67 antigen; carcinoembryonic antigen CGM6; non-specific cross-reacting antigen NCA-95; carcinoembryonic antigen gene family member 6; CD67; NCA-95;
CLC
Charcot-Leyden crystal protein
CLC; Charcot-Leyden crystal protein; eosinophil lysophospholipase; galectin 10; LGALS10; LPPL_HUMAN; lysolecithin acylhydrolase; MGC149659; galectin-10; GAL10; Gal-10; LGALS10A;
CRK
v-crk sarcoma virus CT10 oncogene homolog (avian)
CRK; v-crk sarcoma virus CT10 oncogene homolog (avian); v crk avian sarcoma virus CT10 oncogene homolog; adapter molecule crk; proto-oncogene c-Crk; p38; CRKII; FLJ38130;
CRKL
v-crk sarcoma virus CT10 oncogene homolog (avian)-like
CRKL; v-crk sarcoma virus CT10 oncogene homolog (avian)-like; v crk avian sarcoma virus CT10 oncogene homolog like; crk-like protein;
Dcc
deleted in colorectal carcinoma
DCC; deleted in colorectal carcinoma; netrin receptor DCC; IGDCC1; immunoglobulin superfamily; DCC subclass; member 1; colorectal tumor suppressor; colorectal cancer suppressor; tumor suppressor protein DCC; deleted in colorectal cancer protein; immunoglobulin superfamily DCC subclass member 1; immunoglobulin superfamily, DCC subclass, member 1; CRC18; CRCR1;
FES
feline sarcoma oncogene
FES; feline sarcoma oncogene; feline sarcoma (Snyder Theilen) viral (v fes)/Fujinami avian sarcoma (PRCII) viral (v fps) oncogene homolog; tyrosine-protein kinase Fes/Fps; c fes/fps protein; FPS; Oncogene FES; feline sarcoma virus; p93c-fes; proto-oncogen;
FGR
feline Gardner-Rasheed sarcoma viral oncogene homolog
FGR; feline Gardner-Rasheed sarcoma viral oncogene homolog; SRC2; c-fgr; c-src2; p55-Fgr; p58-Fgr; p55c-fgr; p58c-fgr; tyrosine-protein kinase Fgr; p55-c-fgr protein; c-fgr protooncogene; proto-oncogene c-Fgr; c-src-2 proto-oncogene; proto-oncogene tyrosine-protein kinase FGR; v-fgr feline Gardner-Rasheed sarcoma viral oncogene homolog; Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog;
FOS
FBJ murine osteosarcoma viral oncogene homolog
FOS; FBJ murine osteosarcoma viral oncogene homolog; p55; AP-1; C-FOS; proto-oncogene c-Fos; activator protein 1; cellular oncogene c-fos; G0/G1 switch regulatory protein 7; FBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS);
FOSB
FBJ murine osteosarcoma viral oncogene homolog B
FOSB; FBJ murine osteosarcoma viral oncogene homolog B; protein fosB; activator protein 1; AP 1; DKFZp686C0818; GOS3; GOSB; G0S3; MGC42291; oncogene FOS B; G0/G1 switch regulatory protein 3; AP-1;
HRAS
v-Ha-ras Harvey rat sarcoma viral oncogene homolog
HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; HRAS1; GTPase HRas; p21ras; H-Ras-1; p19 H-RasIDX protein; c-has/bas p21 protein; transforming protein p21; Ha-Ras1 proto-oncoprotein; c-ras-Ki-2 activated oncogene; GTP- and GDP-binding peptide B; transformation gene: oncogene HAMSV; Ras family small GTP binding protein H-Ras; CTLO; HAMSV; K-RAS; N-RAS; RASH1; C-H-RAS; H-RASIDX; C-BAS/HAS; C-HA-RAS1;
KIT
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
KIT; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; PBT; SCFR; C-Kit; CD117; mast/stem cell growth factor receptor Kit; p145 c-kit; proto-oncogene c-Kit; piebald trait protein; soluble KIT variant 1; tyrosine-protein kinase Kit; proto-oncogene tyrosine-protein kinase Kit; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene-like protein;
KRAS
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; KRAS2, v Ki ras2 Kirsten rat sarcoma 2 viral oncogene homolog; GTPase KRas; KRAS1; K-Ras 2; c-Ki-ras; oncogene KRAS2; K-ras p21 protein; c-Kirsten-ras protein; PR310 c-K-ras oncogene; transformi;
LYN
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
LYN; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog; tyrosine-protein kinase Lyn; JTK8; lck/Yes-related novel protein tyrosine kinase; p53Lyn; p56Lyn; FLJ26625;
LYNA
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
LYN; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog; JTK8; FLJ26625; Yamaguchi sarcoma viral (v-yes-1) related oncogene homolog; EC 2.7.10.2;
LYNB
Yamaguchi sarcoma viral (v-yes-1) oncogene homolog
LYN; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog; JTK8; FLJ26625; Yamaguchi sarcoma viral (v-yes-1) related oncogene homolog; EC 2.7.10.2;
SPARCL1
SPARC-like 1 (hevin)
SPARCL1; SPARC-like 1 (hevin); SPARC like 1 (mast9, hevin); SPARC-like protein 1; MAST9; Ecm2; RAGS1 antigen; Extracellular matrix protein 2; Hevin; High endothelial venule protein; MAST 9; Matrix glycoprotein Sc1; PIG33; proliferation inducing protein 33; SC1; SPARC like 1; SPRL1_HUMAN; SPARC-like 1 (mast9, hevin); proliferation-inducing protein 33;
SRC
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog
SRC; v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog; ASV; SRC1; c-SRC; p60-Src; proto-oncogene tyrosine-protein kinase Src; proto-oncogene c-Src; tyrosine kinase pp60c-src; tyrosine-protein kinase SRC-1; protooncogene SRC, Rous sarcoma; EC 2.7.10.2;
SSX4
synovial sarcoma, X breakpoint 4
SSX4; synovial sarcoma, X breakpoint 4; protein SSX4; CT5.4; MGC12411; Synovial sarcoma X breakpoint 4; OTTHUMP00000024292; OTTHUMP00000216158; cancer/testis antigen 5.4; SSX4B;
ST13
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
ST13; suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein); hsc70-interacting protein; FAM10A1; HIP; HSPABP1; P48; progesterone receptor associated p48 protein; SNC6; Hsp70-interacting protein; aging-associated protein 2; putativ;
TDGF1
teratocarcinoma-derived growth factor 1
TDGF1; teratocarcinoma-derived growth factor 1; CR; CRGF; CRIPTO; cripto-1 growth factor; epidermal growth factor-like cripto protein CR1;
YES1
v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1
YES1; v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1; tyrosine-protein kinase Yes; c yes; HsT441; Yes; proto-oncogene c-Yes; cellular yes-1 protein; Yamaguchi sarcoma oncogene; proto-oncogene tyrosine-protein kinase YES; c-yes; P61-YES;
SKI
v-ski avian sarcoma viral oncogene homolog
SKI; v-ski avian sarcoma viral oncogene homolog; SGS; SKV; ski oncogene; ski oncoprotein; proto-oncogene c-Ski;
MYL12A
myosin, light chain 12A, regulatory, non-sarcomeric
MYL12A; myosin, light chain 12A, regulatory, non-sarcomeric; myosin, light polypeptide, regulatory, non sarcomeric (20kD); myosin regulatory light chain 12A; MLCB; MRCL3; MRLC3; MYL2B; myosin regulatory light chain 3; nonsarcomeric; RLC; ML12A_HUMAN; MLC 2B; MLC-2B; Myosin regulatory light chain 2; Myosin regulatory light chain 2, nonsarcomeric; Myosin regulatory light chain MRCL3; Myosin regulatory light chain MRLC3; Myosin RLC; OTTHUMP00000162243; myosin, light polypeptide, regula;
ASPSCR1
alveolar soft part sarcoma chromosome region, candidate 1
ASPSCR1; alveolar soft part sarcoma chromosome region, candidate 1; tether containing UBX domain for GLUT4; ASPL; ASPS; UBX domain protein 9; UBXD9; UBXN9; UBX domain-containing protein 9; alveolar soft part sarcoma locus; renal cell carcinoma, papillary,;
BCAS1
breast carcinoma amplified sequence 1
BCAS1; breast carcinoma amplified sequence 1; breast carcinoma-amplified sequence 1; AIBC1; NABC1; novel amplified in breast cancer 1; amplified and overexpressed in breast cancer;
EWSR1
Ewing sarcoma breakpoint region 1
EWSR1; Ewing sarcoma breakpoint region 1; RNA-binding protein EWS; EWS; Ewings sarcoma EWS-Fli1 (type 1) oncogene; bK984G1.4;
ICT1
immature colon carcinoma transcript 1
ICT1; immature colon carcinoma transcript 1; peptidyl-tRNA hydrolase ICT1, mitochondrial; DS 1; Digestion substraction 1; DS1; Immature colon carcinoma transcript 1 protein; DS-1;
SGCA
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
SGCA; sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein); ADL, sarcoglycan, alpha (50kD dystrophin associated glycoprotein); alpha-sarcoglycan; 50kD DAG; A2; adhalin; adhalin (limb girdle muscular dystrophy 2D); DMDA2; LGMD2D; Sarcoglycan; alpha (50kD dystrophin associated glycoprotein; adhalin); SCARMD1; 50DAG; 59kDa; ADL; DAG2; 50 DAG; 50 kDa dystrophin associated glycoprotein; 50 kDa dystrophin-associated glycoprotein; Alpha SG; Alpha-SG; Asg; Dystroglycan 2; Dystroglycan-2; sarcoglycan, alpha (dystrophin-associated glycoprotein); SGCA_HUMAN; OTTHUMP00000221051; OTTHUMP00000221052; OTTHUMP00000221053; 50-DAG;
SGCB
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)
SGCB; sarcoglycan, beta (43kDa dystrophin-associated glycoprotein); LGMD2E, sarcoglycan, beta (43kD dystrophin associated glycoprotein); beta-sarcoglycan; A3b; SGC; 43DAG; beta-SG; 43 kDa dystrophin-associated glycoprotein; limb girdle muscular dystrophy;
SLMAP
sarcolemma associated protein
SLMAP; sarcolemma associated protein; sarcolemmal membrane-associated protein; KIAA1601; Sarcolemmal associated protein; SLAP; Sarcolemmal-associated protein; FLJ42206; MGC138760; MGC138761;
ST14
suppression of tumorigenicity 14 (colon carcinoma)
ST14; suppression of tumorigenicity 14 (colon carcinoma); HAI; MTSP1; SNC19; ARCI11; MT-SP1; PRSS14; TADG15; TMPRSS14; suppressor of tumorigenicity 14 protein; prostamin; serine protease 14; serine protease TADG-15; membrane-type serine protease 1; tumor associated differentially expressed gene 15 protein; tumor-associated differentially-expressed gene 15 protein; suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin);
STBD1
starch binding domain 1
STBD1; starch binding domain 1; starch-binding domain-containing protein 1; FLJ41801; genethonin 1; GENX 3414; Genethonin1; GENEX 3414; GENEX3414; GENX3414; Starch binding domain containing protein 1; STBD 1; OTTHUMP00000160602; GENX-3414;
SSX1
synovial sarcoma, X breakpoint 1
SSX1; synovial sarcoma, X breakpoint 1; protein SSX1; cancer/testis antigen family 5; member 1; CT5.1; X breakpoint 1; Cancer/testis antigen 5.1; Cancer/testis antigen family 5 member 1; MGC150425; MGC5162; sarcoma, synovial, X chromosome related 1; SSRC; SSX1_HUMAN; Synovial sarcoma; cancer/testis antigen family 5, member 1; sarcoma, synovial, X-chromosome-related 1;
SSX2
synovial sarcoma, X breakpoint 2
SSX2; synovial sarcoma, X breakpoint 2; SSX; protein SSX2; cancer/testis antigen family 5; member 2a; CT5.2a; HD21; HOM MEL 40; MGC3884; MGC15364; MGC119055; sarcoma; synovial; X chromosome related 2; synovial sarcoma; X breakpoint 2; isoform b; X breakpo;
MAFG
v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)
MAFG; v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian); v maf musculoaponeurotic fibrosarcoma (avian) oncogene family, protein G; transcription factor MafG; basic leucine zipper transcription factor MafG; MGC13090; MGC20149; hMAF;
FAU
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed
FAU; Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed; Finkel Biskis Reilly murine sarcoma virus (FBR MuSV) ubiquitously expressed (fox derived); ubiquitin-like protein fubi and ribosomal protein S30; asr1; FLJ22986; Fub1; Fubi;
MAF
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
MAF; v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian); v maf musculoaponeurotic fibrosarcoma (avian) oncogene homolog; transcription factor Maf; c MAF; AS42 oncogene homolog; Avian musculoaponeurotic fibrosarcoma (MAF) protooncogene; Avian musculoaponeurotic fibrosarcoma (v maf); c maf proto oncogene; cMaf; MAF_HUMAN; MAF2; MGC71685; Proto oncogene c Maf; Proto-oncogene c-maf; v maf musculoaponeurotic fibrosarcoma oncogene homolog (avian); v maf musculoaponeurotic fibrosarcoma oncogene homolog; V-maf musculoaponeurotic fibrosarcoma oncogene homolog; OTTHUMP00000174965; OTTHUMP00000196745; c-maf proto-oncogene; T lymphocyte c-maf long form; c-MAF;
MAFA
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
MAFA; v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A; hMafA; RIPE3b1; transcription factor MafA; transcription factor RIPE3b1; pancreatic beta-cell-specific transcriptional activator;
MARCKSL1
MARCKS-like 1
MARCKSL1; MARCKS-like 1; MARCKS-related protein; macMARCKS; mac-MARCKS; brain protein F52; MARCKS-like protein 1; myristoylated alanine-rich C kinase substrate; macrophage myristoylated alanine-rich C kinase substrate; F52; Mlp; MGC93399;
SGCD
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
SGCD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); sarcoglycan, delta (35kD dystrophin associated glycoprotein); delta-sarcoglycan; CMD1L; DAGD; LGMD2F; 35 kDa dystrophin associated glycoprotein; 35 kDa dystrophin-associated glycoprotein; 35DAG; Delta-SG; Dystrophin associated glycoprotein delta sarcoglycan; MGC22567; Sarcoglycan delta (35 kDa dystrophin associated glycoprotein); SG delta; SGCD_HUMAN; SGCDP; SGD; OTTHUMP00000223946; OTTHUMP00000223947; OTTHUMP00000223961; placental delta sarcoglycan; 35kD dystrophin-associated glycoprotein; dystrophin associated glycoprotein, delta sarcoglycan; SG-delta;
SGCG
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
SGCG; sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein); DMDA1, LGMD2C, MAM, sarcoglycan, gamma (35kD dystrophin associated glycoprotein); gamma-sarcoglycan; 35kD dystrophin associated glycoprotein; A4; DAGA4; DMDA; gamma sarcoglycan; limb girdle muscular dystrophy 2C (Duchenne like muscular dystrophy; autosomal recessive); Maghrebian myopathy (autosomal recessive); MGC130048; SCARMD2; SCG3; TYPE; 35 kDa dystrophin associated glycoprotein; Gamma SG; 35 kDa dystrophin-associated glycoprotein; 35DAG; DMDA1; Gamma-SG; LGMD2C; MAM; Sarcoglycan gamma; SGCG_HUMAN; OTTHUMP00000018112; 35kD dystrophin-associated glycoprotein;
SPOCK3
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3
SPOCK3; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3; testican-3; testican 3; HSAJ1454; OTTHUMP00000219853; OTTHUMP00000219854; OTTHUMP00000219857; OTTHUMP00000219858; OTTHUMP00000219862; OTTHUMP00000219864; OTTHUMP00000219865; OTTHUMP00000219866; OTTHUMP00000219867; OTTHUMP00000219868; Sparc/osteonectin, cwcv and kazal like domains proteoglycan (testican) 3; SPARC/osteonectin, CWCV, and Kazal like domains proteoglycan 3; TES 3; TICN3; TES-3;
SS18
synovial sarcoma translocation, chromosome 18
SS18; synovial sarcoma translocation, chromosome 18; SSXT; protein SSXT; SYT; MGC116875; Protein SYT; SSXT/SSX4v fusion; SSXT_HUMAN; Synovial sarcoma translocated to X chromosome; Synovial sarcoma translocated to X chromosome protein; Synovial sarcoma translocation chromosome 18; SYT SSX1; SYT SSX2; SYT/SSX4v fusion protein; SYTSSX1; SYTSSX2; synovial sarcoma, translocated to X chromosome;
SSX3
synovial sarcoma, X breakpoint 3
SSX3; synovial sarcoma, X breakpoint 3; protein SSX3; CT5.3; MGC119054; Cancer/testis antigen 5.3; MGC14495; SSX3_HUMAN; synovial sarcoma, X breakpoint 3, isoform a;
CEACAM19
carcinoembryonic antigen-related cell adhesion molecule 19
CEACAM19; carcinoembryonic antigen-related cell adhesion molecule 19; CEAL1; Carcinoembryonic antigen like 1; Carcinoembryonic antigen related cell adhesion molecule 19; CEA related cell adhesion molecule 19; MGC105097; OTTHUMP00000200169; OTTHUMP00000200170; carcinoembryonic antigen-like 1;
CEACAM20
carcinoembryonic antigen-related cell adhesion molecule 20
CEACAM20; carcinoembryonic antigen-related cell adhesion molecule 20; UNQ9366; carcinoembryonic antigen related cell adhesion molecule 20; GPAD9366;
CEACAM7
carcinoembryonic antigen-related cell adhesion molecule 7
CEACAM7; carcinoembryonic antigen-related cell adhesion molecule 7; CGM2; carcinoembryonic antigen gene family member 2; CEA; Carcinoembryonic antigen CGM 2; Carcinoembryonic antigen CGM2; Carcinoembryonic antigen related cell adhesion molecule 7; CEACAM 7; CGM 2; OTTHUMP00000199040; OTTHUMP00000199041;
CKMT2
creatine kinase, mitochondrial 2 (sarcomeric)
CKMT2; creatine kinase, mitochondrial 2 (sarcomeric); creatine kinase S-type, mitochondrial; SMTCK; CKMT 2; mitochondrial; Basic-type mitochondrial creatine kinase; CPK; Creatine kinase mitochondrial 2; Creatine kinase mitochondrial 2 (sarcomeric); Creatine kinase S-type; KCRS_HUMAN; Mib CK; Mib-CK; S-MtCK; Sarcomeric mitochondrial creatine kinase;
FUS
fused in sarcoma
FUS; fused in sarcoma; TLS; ALS6; ETM4; FUS1; POMP75; HNRNPP2; RNA-binding protein FUS; oncogene FUS; oncogene TLS; fus-like protein; 75 kDa DNA-pairing protein; fusion gene in myxoid liposarcoma; translocated in liposarcoma protein; heterogeneous nuclear ribonucleoprotein P2;
MYCL1
v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)
MYCL1; v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian); MYCL, v myc avian myelocytomatosis viral oncogene homolog 1, lung carcinoma derived; protein L-Myc-1; bHLHe38; l myc protein; LMYC; myc related gene from lung cancer; oncogene lmyc; l myc 1 proto oncogene; L myc 1 proto-oncogene protein; MYCL 1; MYCL; v myc avian myelocytomatosis viral oncogene homolog 1 lung carcinoma derived; l-myc-1 proto-oncogene; myc-related gene from lung cancer; class E basic helix-loop-helix protein 38;
NOL3
nucleolar protein 3 (apoptosis repressor with CARD domain)
NOL3; nucleolar protein 3 (apoptosis repressor with CARD domain); ARC; FCM; MYP; NOP; NOP30; nucleolar protein 3; nucleolar protein of 30 kDa; muscle-enriched cytoplasmic protein;
BCAS3
breast carcinoma amplified sequence 3
BCAS3; breast carcinoma amplified sequence 3; breast carcinoma-amplified sequence 3; FLJ20128; 1500019F07Rik; 2610028P08Rik; AU021018; BC028339; BCAS3_HUMAN; GAOB1; K20D4; MAAB; Maab1 protein; MGC4973; rudhira; protein Maab1; BCAS4/BCAS3 fusion; metastasis associated antigen of breast cancer; breast carcinoma amplified sequence 4/3 fusion protein;
AMZ2
archaelysin family metallopeptidase 2
AMZ2; archaelysin family metallopeptidase 2; archaemetzincin-2; archaemetzincin 2; archaemetzincins-2; archeobacterial metalloproteinase-like protein 2;
AMZ1
archaelysin family metallopeptidase 1
AMZ1; archaelysin family metallopeptidase 1; archaemetzincin-1; archaemetzincin 1; KIAA1950; metalloproteinase-like protein; archeobacterial metalloproteinase-like protein 1;
BCAS4
breast carcinoma amplified sequence 4
BCAS4; breast carcinoma amplified sequence 4; breast carcinoma-amplified sequence 4; CNOL; FLJ20495; BCAS4/BCAS3 fusion; breast carcinoma amplified sequence 4/3 fusion protein;
CEACAM4
carcinoembryonic antigen-related cell adhesion molecule 4
CEACAM4; carcinoembryonic antigen-related cell adhesion molecule 4; CGM7; carcinoembryonic antigen CGM7; nonspecific cross-reacting antigen W236; Nonspecific cross-reacting antigen (NCA); non-specific cross-reacting antigen W236; carcinoembryonic antigen;
CEACAM21
carcinoembryonic antigen-related cell adhesion molecule 21
CEACAM21; carcinoembryonic antigen-related cell adhesion molecule 21; FLJ13540; R29124_1; Carcinoembryonic antigen related cell adhesion molecule 21; CEA21_HUMAN; CEACAM3; MGC119874; OTTHUMP00000199036;
MOS
v-mos Moloney murine sarcoma viral oncogene homolog
MOS; v-mos Moloney murine sarcoma viral oncogene homolog; proto-oncogene serine/threonine-protein kinase mos; c-mos; proto-oncogene c-Mos; oocyte maturation factor mos; oncogene MOS, Moloney murine sarcoma virus; MSV; MGC119962; MGC119963;
PRCC
papillary renal cell carcinoma (translocation-associated)
PRCC; papillary renal cell carcinoma (translocation-associated); proline-rich protein PRCC; RCCP1; papillary renal cell carcinoma translocation-associated gene protein; TPRC; MGC4723; MGC17178;
MAFB
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
MAFB; v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B; KRML; MCTO; transcription factor MafB; Kreisler maf-related leucine zipper homolog; MAFB/Kreisler basic region/leucine zipper transcription factor;
MAFF
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F
MAFF; v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F; U-MAF; hMafF; transcription factor MafF; v-maf avian musculoaponeurotic fibrosarcoma oncogene family protein F;
SSX5
synovial sarcoma, X breakpoint 5
SSX5; synovial sarcoma, X breakpoint 5; protein SSX5; SSX5_HUMAN;
SSX2IP
synovial sarcoma, X breakpoint 2 interacting protein
SSX2IP; synovial sarcoma, X breakpoint 2 interacting protein; afadin- and alpha-actinin-binding protein; SSX2-interacting protein; afadin DIL domain-interacting protein; ADIP; FLJ10848; KIAA0923; MGC75026;
SART1
squamous cell carcinoma antigen recognized
SART1; squamous cell carcinoma antigen recognized; squamous cell carcinoma antigen recognised by T cells; U4/U6.U5 tri-snRNP-associated protein 1; Ara1; small nuclear ribonucleoprotein 110kDa (U4/U6.U5); SNRNP110; Snu66; Ara 1; HOMS 1; HOMS1; hSART 1; hSART1; hSnu 66; hSnu66; IgE autoantigen; SART 1; SART1 259; SART1(259) protein; SART1(800) protein; SART1259; Snu 66; Squamous cell carcinoma antigen recognized by T cells 1; U4/U6.U5 tri snRNP associated 110 kDa protein; U4/U6.U5 tri snRNP associated protein 1; SART-1; hSART-1; SNU66 homolog; U4/U6.U5 tri-snRNP-associated 110 kDa protein;
SART3
squamous cell carcinoma antigen recognized
SART3; squamous cell carcinoma antigen recognized; squamous cell carcinoma antigen recognised by T cells 3; squamous cell carcinoma antigen recognized by T-cells 3; KIAA0156; RP11 13G14; hSART 3; p110(nrb); RP11-13G14; Tat interacting protein of 110 kDa; TIP110; SART-3; hSART-3; tat-interacting protein of 110 kDa; P100; p110; DSAP1;
SPOCK1
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
SPOCK1; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1; sparc/osteonectin, cwcv and kazal like domains proteoglycan (testican) , SPOCK, TIC1; testican-1; testican 1; Sparc/osteonectin, cwcv and kazal like domains proteoglycan 1; SPOCK; TIC1; TICN1; TESTICAN;
SSX4B
synovial sarcoma, X breakpoint 4B
SSX4B; synovial sarcoma, X breakpoint 4B; protein SSX4; OTTHUMT00000056510; Cancer/testis antigen 5.4; CT5.4; MGC119056; MGC12411; MGC169015; MGC169016; SSX4; SSX4A; Synovial sarcoma X breakpoint 4; Synovial sarcoma X breakpoint 4B;
SMOC2
SPARC related modular calcium binding 2
SMOC2; SPARC related modular calcium binding 2; SPARC-related modular calcium-binding protein 2; SMAP2; SMAP-2; SMOC-2; smooth muscle associated protein 2; smooth muscle-associated protein 2; secreted modular calcium-binding protein 2; thyroglobulin type-;
SPOCK2
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
SPOCK2; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2; testican-2; KIAA0275; testican 2; and Kazal-like domains proteoglycan 2; CWCV; FLJ97039; SPARC/osteonectin; Sparc/osteonectin cwcv and kazal like domains proteoglycan (testican) 2; Sparc/osteonectin cwcv and kazal like domains proteoglycan 2; SPOCK 2; Testican2; TICN 2; TICN2; TICN2_HUMAN; SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2;
SS18L2
synovial sarcoma translocation gene on chromosome 18-like 2
SS18L2; synovial sarcoma translocation gene on chromosome 18-like 2; SS18-like protein 2; KIAA iso; SYT homolog 2; SS18 like protein 2; Synovial sarcoma translocation gene on chromosome 18 like 2; KIAA-iso;
SSPN
sarcospan (Kras oncogene-associated gene)
SSPN; sarcospan (Kras oncogene-associated gene); KRAG; sarcospan; SPN1; SPN2; K ras oncogene associated gene; K ras oncogene associated protein; Kirsten ras associated protein; microspan; Kirsten-ras associated; kirsten-ras-associated protein; K-ras oncogene-associated protein; NSPN; DAGA5; nanospan;
SS18L1
synovial sarcoma translocation gene on chromosome 18-like 1
SS18L1; synovial sarcoma translocation gene on chromosome 18-like 1; calcium-responsive transactivator; KIAA0693; SS18; SS18-like protein 1; SSXT; synovial sarcoma translocation; SYT homolog 1; CREST; LP2261;
ARC
activity-regulated cytoskeleton-associated protein
ARC; activity-regulated cytoskeleton-associated protein; Arg3.1; ARC/ARG3.1; activity-regulated gene 3.1 protein homolog;
CEACAM16
carcinoembryonic antigen-related cell adhesion molecule 16
CEACAM16; carcinoembryonic antigen-related cell adhesion molecule 16; Carcinoembryonic antigen like 2; Carcinoembryonic antigen like 2 protein; Carcinoembryonic antigen related cell adhesion molecule 16; CEAL2; carcinoembryonic antigen-like 2; carcinoembryonic antigen like-2 protein;
ARCN1
archain 1
ARCN1; archain 1; coatomer protein complex, subunit delta , COPD; coatomer subunit delta; Archain; Delta coat protein; Delta COP; delta-COP; delta-coat protein; coatomer delta subunit; coatomer protein delta-COP; archain vesicle transport protein 1; coatomer protein complex, subunit delta; COPD;
OS9
osteosarcoma amplified 9, endoplasmic reticulum lectin
OS9; osteosarcoma amplified 9, endoplasmic reticulum lectin; OS-9; ERLEC2; protein OS-9; erlectin 2; amplified in osteosarcoma 9; endoplasmic reticulum lectin 2; osteosarcoma amplified 9, endoplasmic reticulum associated protein;
ST18
suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein)
ST18;suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein);18695;ENSG00000147488;ZNF387;8q11.23;KIAA0535;suppression of tumorigenicity 18 protein;suppression of tumorigenicity 18 protein;zinc finger protein 387;
Ceacam12
carcinoembryonic antigen-related cell adhesion molecule 12
Ceacam12C1; Ceacam12C3; Ceacam12-C1; Ceacam12-C3; 1600031J20Rik;
Ceacam14
carcinoembryonic antigen-related cell adhesion molecule 14
AV033953; 1600021E03Rik; 1600025E09Rik;
CD66a
carcinoembryonic antigen-related cell adhesion molecule 1
Bgp; Cc1; Hv2; Bgp1; Cea1; Cea7; Hv-2; MHVR; bb-1; C-CAM; CD66a; Cea-1; Cea-7; MHVR1; Mhv-1; mCEA1; mmCGM1; mmCGM2; mmCGM1a;
CD66c
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
NCA; CEAL; CD66c;
Protein Structure: Researchers Found How Viral Protein Suppresses Immune Protein
The innate immune system, the first line of defense against pathogens and noxious chemicals, detects invasive pathogens and activates defense mechanisms to eliminate them. The defense system is made up of an array of receptors that are in charge of recognizing specific molecular conformations of...
Cell: Researchers Found a Novel Rule of Membrane Proteins
Like the teeth of a zipper, the charged amino acids (as the red and blue color show) form connections between protein segments and thus form pores in the cell membrane. Membrane proteins, attached to or associated with themembraneof acellor anorganelle, perform a variety of functions vita...
Researchers Developed a Model That Explains How Nucleosomes Recognize Protein
The pictures shows the model how proteins move along DNA Most of the DNA in evolved organisms is wrapped around proteins, forming the basic unit of DNA packaging, nucleosomes as the picture shows. But how exactly these nucleosomes are recognized and read by protein is unclear. In order to fin...
Researchers Developed New Antibiotic for Broad-range and “Resistance-free”
The scanning electron micrograph shows macrophages infected with Bacillus anthracis Viruses using phage attack bacteria. With billions of years experience, phages have trained their unique armor to infect bacterial via the weak point. In order to fig...
Researchers Discovered the Energy and Pathway of Opening and Closing of Ion Channel
Ion channelsare pore-formingmembraneproteins. They are important components in many biological processes that involve rapid changes in cells, for example,cardiac,skeletal, andsmooth musclecontraction,epithelialtransport of nutrients and ions,T-cellactivation andpancreaticbeta-cellinsulinrele...
Stat5 Protein is an Important Target for the Research of Prostate Cancer
Among many factors that affect prostate cancer, Stat5 is one of the important. As early as in 2003, scientists have discovered that Stat5 protein is critical for viability of prostate cancer cells and growth of prostate tumors in mice. In 2005, researchers demonstrated that Stat5 activity was assoc...
Researchers Found a Genetic Reason of Anemia-Atpifl
Loss of Atpifl gene might cause anemia Anemia can affect people of all ages. It is a condition in which peoples blood has a lower number of red blood cells or hemoglobin levels than normal. Women of childbearing age and older adults are at higher risk. Babies and children are also at risk for anemi...
Methionine Adenosyltransferase II alpha Related Researches and Products
Methionine adenosyltransferase II alpha (MAT2A) is an essential enzyme that is in charge of S-adenosylmethionine (SAMe) biosynthesis. It is extensively distributed within body. In liver, increased MAT2A expression correlates with growth, while SAMe inhibits MAT2A expression and growth. Thus ...
Lipid-based Protein Immobilization—A Novel Membrane Protein Research Tool
Lipid-based Protein Immobilization, or LPI, allows for immobilization and work-up of intact, native membrane proteins. Lipid-based Protein Immobilization allows immobilization of cell vesicles with intact, conformationally correct membrane pr...
Drug Resistance Antibodies Speed Up Cancer Researches
Drug resistance could be a severe problem in the way of benefiting eventual health care. Drug resistance, also known as antimicrobial resistance, occurs when microorganisms (including bacteria, viruses, fungi and parasites) change in ways that render the medications used to cure the infection...
Creative BioMart Enhances Technologies and Products for Use in Biomedical Research
Creative BioMart, one of the world's leading manufacturers of recombinant proteins and biosimilar cell lines, has used over 10 years of experience in the specialty biosimilar sector to enhance its technologies and products, including the featured gene screening and amplification system, for use in t...
Statistics: Research Focus Is Put on Recombinant Proteins
According to the results of one of our online surveys, most listed companies have placed their emphasis on the development of recombinant proteins. Meanwhile according to the statistics of financial weekly newspaper, nine pharmaceutical...
Basic Research Confirmed a Rare Structure of RNA
As early as in 1961, a scientist had proposed the hypothesis that poly (rA), RNA, may form a parallel chain of double stranded structure. Lately Canadian scientists successfully confirmed the hypothesis with a short crystal RNA sequencepoly (rA)...
A New Patent of Monoclonal Antibodies for the Treatment of Serious Diseases Research and Development Registered
On Dec. 21, 2012, one of our peer companies, Immunomedics, Inc. (Nasdaq:IMMU) announced that it has received notice its patent application for Anti-CD19 antibodies which would be issued as US patent No. 8,337,840 on Dec. 25, 2012. IMMU primarily attaches importance to the development o...
Creative BioMart Releases New products for H7N9 Research
During the past two months, China, especially the eastern China and the world suffered the threats of novel coronavirus— H7N9. Till May 27, 130 cases were diagnosed in mainland China. Until May 28, all the infected areas announced the stop of emergency response. But the stop doesn’t mean people sto...
What is SMARCA4 Protein
See All SMARCA4 Products The SMARCA4 gene, also known as BRG1 or SNF2β, delivers instructions for generating a crucial component of the SWI/SNF chromatin remodeling complex called SMARCA4 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 4). The discove...
What is MARCKS Protein?
See All MARCKS Products The myristoylated alanine-rich C-kinase substrate (MARCKS) is a protein that plays a fundamental role in the proper functioning of the human body. This protein was discovered by McLaughlin and Aderem in 1980 during studies examining the regulation of actin cytoskeleton (struc...
